Collateral for a security interest recorded Jan 2, 2024 (Natixis).
Term ends Mar 30, 2027 · High confidence
20-year base term ends Mar 30, 2027
Held by Biomune Company
Filed Aug 28, 2018 as application 16/114,265 · Granted May 19, 2020
Base term, 20 years from filing
Today
2007
2027
Clock starts
Mar 30, 2007
Mar 30, 2007
Term ends
Mar 30, 2027
Mar 30, 2027
Granted
May 19, 2020
May 19, 2020
base term
fee events
Updated Nov 14, 2026 · includes USPTO assignment & status data published Nov 14, 2026 and grant & fee data published Nov 10, 2026 (weekly) · how we know
None
Term adjustment
No prosecution delay on this record.
No effect
Terminal disclaimer
Resolved from the filed document, referencing US 10,072,272, US 8,927,270, to Mar 30, 2027. The term already ends on or before that date, so the cap shortened nothing.
1 of 1
Maintenance fees paid
One maintenance fee can end this term early, the one due 3.5 years from grant; the next one's grace period runs past the term end. This counts it if the record shows it paid.
5
Family applications on record here
Applications sharing this one's continuity chain whose file history this site holds. The family may have others.
This patent's term is its 20-year base term, with no adjustment for prosecution delay. A terminal disclaimer is resolved from the filed document, and it ends no earlier than this term, so it shortens nothing. 1 of 1 maintenance fees is paid so far. Confidence: High. from the record
How we calculated this date
One row per rule, each showing its own input and what it did to the date. A step we could not verify says so instead of resolving itself.
| Step | Input | Date after this step | Confidence |
|---|---|---|---|
| Base term, 20 years from filing | Clock starts Mar 30, 2007, when application 11/729,978, the earliest non-provisional in its chain, was filed (this one was filed Aug 28, 2018) | Mar 30, 2027 | High confidence |
| Continuity chain | Every parent in the chain resolved | no change | High confidence |
| Patent term adjustment | None on file | no change | High confidence |
| Terminal disclaimer cap | Disclaimer resolved from the filed document (refs US 10,072,272, US 8,927,270) | resolves to Mar 30, 2027, no earlier than this term, so no change | High confidence |
| Patent term extension | None on file | no change | High confidence |
| Fee events | 1 of 1 maintenance fees paid | In force | High confidence |
| Computed term end | The steps above, in order | Mar 30, 2027 | High confidence |
This family
| Application 11/729,978 | Abandoned not computed | not computed |
| Application PCT/US2008/004070 | PCT application no patent term | no patent term |
| US 8,927,270 | In force Dec 2029 | Dec 2029 |
| US 10,072,272 | In force Mar 2027 | Mar 2027 |
| US 10,655,146 | this patent Mar 2027 | Mar 2027 |
The applications whose file history this site holds. The family may have others.
Assignments
Assignment documents as recorded at the USPTO, oldest first, with the reel and frame each was recorded at. A recorded assignment is a filed document, not a statement of current ownership, and the absence of a later one is not evidence that the last one still stands.
| Recorded | Assignor | Assignee | Conveyance |
|---|---|---|---|
| Aug 28, 2018 Reel 46727, frame 241 | Esaki, Motoyuki; Jensen, Lauren Elizabeth; Dorsey, Kristi M. | Zeon Corporation | Assignment of Assignor's Interest |
| Aug 29, 2018 Reel 46732, frame 14 | Zeon Corporation | Biomune Company | Assignment of Assignor's Interest |
| Jan 2, 2024 Reel 66163, frame 711 | Ceva Animal Health, LLC; Biomune Company; Thundershirt, LLC | Natixis, As Security Agent | Notice of Grant of Security Interest in Patents |
Sources
Google Patents · The patent document at USPTO · Assignment records at USPTO
USPTO account required: This application in Patent Center · USPTO's maintenance fee lookup
Maintenance fee events come from USPTO's own fee records. Its fee lookup asks for the patent number and the application number.
What's changing
Mar 2027
Term ends Mar 30, 2027. No further fees fall due before then
Terminal disclaimer
A terminal disclaimer resolved from the filed document, referencing US 10,072,272, US 8,927,270, ends no earlier than this term, so it caps nothing.
Citations
2
later US patents cite this one
That is below the median of utility patents granted in 2020 in our data, the only group it is compared against.
How we rank
Every date shows its work: the base term, any term adjustment or extension, any disclaimer cap, and the maintenance fee record, each with a confidence tier. How this record was built
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.
In force means the term is running and no lapse is on record. It is not a finding that the patent is valid.